Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Jun 14, 2024
Open Peer Review Period: Jul 2, 2024 - Aug 27, 2024
Date Accepted: Feb 6, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Transformer-Based Language Models for Group Randomized Trial Classification in Biomedical Literature: Model Development and Validation

Elaheh E, Murray D

Transformer-Based Language Models for Group Randomized Trial Classification in Biomedical Literature: Model Development and Validation

JMIR Med Inform 2025;13:e63267

DOI: 10.2196/63267

PMID: 40344669

PMCID: 12148241

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Using Transformer-based Language Models to Identify Publications from Clinical Trials that Use Nested Designs

  • Elaheh Elaheh; 
  • David Murray

ABSTRACT

Background:

For the public health community, monitoring recently published articles is crucial for staying informed about the latest research developments and advancements. However, identifying publications with specific research designs from the extensive body of public health publications is a challenge with currently available methods. Using search queries to retrieve publications of this type often yields low sensitivity, failing to identify many qualifying publications. While document classification techniques like classical and deep learning machine learning models have been widely used for categorizing biomedical documents, the use of state-of-the-art language models for this purpose has yet to be explored. The language models pre-trained on biomedical data that do exist have suboptimal performance in predicting categories in specialized tasks like identifying publications from clinical trials that use nested designs.

Objective:

Our objective is to develop a fine-tuned pre-trained language model that can accurately identify publications from clinical trials that use a Group- or Cluster-Randomized Trial (GRT), Individually Randomized Group-Treatment Trial (IRGT), or Stepped Wedge Group- or Cluster-Randomized Trial (SWGRT) design within the biomedical literature.

Methods:

We fine-tuned the BiomedBERT language model using a dataset of biomedical literature from the Office of Disease Prevention at the National Institutes of Health. The model was trained to classify publications into three categories of clinical trials that use nested designs. The model performance was evaluated on unseen data and demonstrated high sensitivity and specificity for each class.

Results:

When our proposed model was tested for generalizability with unseen data, it delivered high sensitivity and specificity for each class as follows: Non-randomized trials (0.95 and 0.93), GRTs (0.94 and 0.90), IRGTs (0.81 and 0.97), and SWGRTs (0.96 and 0.99), respectively.

Conclusions:

This model offers a valuable tool for the public health community to directly identify publications from clinical trials that use one of three classes of nested designs.


 Citation

Please cite as:

Elaheh E, Murray D

Transformer-Based Language Models for Group Randomized Trial Classification in Biomedical Literature: Model Development and Validation

JMIR Med Inform 2025;13:e63267

DOI: 10.2196/63267

PMID: 40344669

PMCID: 12148241

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.